Moderna Talking to U.S. About Shots for Low-Income Countries

Moderna Inc. is interested in partnering with the U.S. government on possibly providing additional doses of it Covid-19 vaccine to help address the pandemic in low- and middle-income countries, the company said.

Spokesman Ray Jordan said in an email that the company wouldn’t provide additional details about any particular talks.

Moderna is in the process of expanding its manufacturing capacity so it can produce up to 3 billion vaccine doses next year, compared with its goal of up to 1 billion this year.

The talks between Moderna and the U.S. were reported earlier by CNBC.

The U.S. appears to be ramping up efforts to supply vaccine to poorer countries as its domestic immunization campaign is slowing down. More than half of Americans have received at least one vaccine dose, according to Bloomberg’s Vaccine Tracker.

The Biden administration also intends to buy 500 million doses of Pfizer Inc.’s vaccine to share internationally. The government will purchase about 200 million doses this year to distribute through Covax, the World Health Organization-backed initiative aimed at securing an equitable global vaccine distribution, and about 300 million doses in the first half of next year.

Both the Moderna and the Pfizer vaccines require two doses given several weeks apart to provide maximum protection from the coronavirus.

©2021 Bloomberg L.P.

BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.